<DOC>
	<DOCNO>NCT02310607</DOCNO>
	<brief_summary>This study aim evaluate prototype device detect zinc protoporphyrin-IX fluorescence non-invasively intact oral mucosa . Zinc protoporphyrin-IX establish indicator iron deficiency . The prototype device use measure erythrocyte zinc protoporphyrin-IX/heme ratio woman delivery , study group choose elevate risk iron deficiency . The result non-invasive measurement compare reference measurement erythrocyte zinc protoporphyrin-IX/heme ratio residual blood sample patient indicator iron status , include hemoglobin , ferritin , serum iron , transferrin , transferrin saturation soluble transferrin receptor . Funding Source - Nestec Ltd .</brief_summary>
	<brief_title>Non-invasive Optical Detection Iron Deficiency</brief_title>
	<detailed_description>This trial proof-of-concept study use prototype fiber optic fluorometer acquire autofluorescence spectra woman delivery determine erythrocyte zinc protoporphyrin-IX fluorescence intensity spectrum . The non-invasively determined fluorescence spectrum evaluate provide quantitative measure erythrocyte zinc protoporphyrin-IX/heme concentration ratio . These value primarily compare erythrocyte zinc protoporphyrin-IX determine HPLC residual blood sample subject secondarily erythrocyte zinc protoporphyrin-IX/heme ratio determine use commercial hematofluorometer ( AVIV , model 206d ) indicator iron status , include hemoglobin , ferritin , serum iron , transferrin , transferrin saturation soluble transferrin receptor This study could help establish non-invasive fluorescence measurement zinc protoporphyrin-IX rapid , easy use mean point-of-care screen iron deficiency resource-limited setting lack laboratory infrastructure .</detailed_description>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<criteria>Women delivery term infant Pregnancy delivery without studyrelevant complication Hb value prepartum great equal 12 g/dL less equal 11 g/dL Regular blood withdrawal delivery clinical indication Informed consent participation study Age 18 old Patients legally competent Transfusion blood product course delivery Thalassemia sickle cell anemia Any acute chronic infectious inflammatory disease Insufficient amount residual blood clinically indicate post partum sample</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Post-partum woman</keyword>
</DOC>